Regulatory Listing; Technical Description - Invacare Solo2 TPO100B Internal Repair Manual

2 OVERVIEW
2.3

Regulatory Listing

ETL certified complying with:
2.4

Technical Description

The oxygen concentration level of the output gas ranges from 87% to 95.6%. The oxygen is delivered to the patient through the use of a nasal cannula.
The transportable oxygen concentrator provides two modes of operation; pulse flow and continuous flow. In pulse flow, when the demand for oxygen
is detected, the oxygen is delivered with pulse flow settings of 1 through 5. In continuous flow, oxygen is continuously flowing with settings from 0.5
LPM to 3.0 LPM.
The Invacare transportable oxygen concentrator uses a molecular sieve and pressure swing adsorption methodology to produce the oxygen gas
output. Ambient air enters the device, is filtered and then compressed. This compressed air is then directed toward one of two nitrogen adsorbing
sieve beds. Concentrated oxygen exits the opposite end of the active sieve bed and is directed into an oxygen reservoir where it is delivered to the
patient in specific volumes during the inhalation portion of a detected breath.
The Invacare transportable oxygen concentrator is capable of operation by the patient in a home environment, in an institutional environment or in
a vehicle or other mobile environment. Device standard power options include an AC to DC switching power supply operating from AC power outlet
(120 VAC/ 60 Hertz or 230VAC/50 Hertz nominal), a DC supply operating from accessory outlets typically found in a mobile vehicle type environment
(12 VDC nominal) and a rechargeable battery module.
Invacare® Solo2™ Portable Oxygen Concentrator
EN 55011: 1998
CISPR 11: 2003
IEC 60601-1: 2005
IEC 60601-1-2: 2.1 Ed.
IEC 61000-3-2: 2005
IEC 61000-3-3: 2005
UL 60601-1, 1st ed.
CSA 601.1 M90
ISO 8359
12
Part No 1176122